Cargando…

Primary Melanoma Characteristics of Metastatic Disease: A Nationwide Cancer Registry Study

SIMPLE SUMMARY: Melanoma of the skin is the most lethal form of skin cancer. Almost 40% of the patients who die of metastatic melanoma did not have metastases at first diagnosis. More knowledge about patient and tumour characteristics as well as patterns of disease progression is needed. We describe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Catherine, Louwman, Marieke, Wakkee, Marlies, van der Veldt, Astrid, Grünhagen, Dirk, Verhoef, Cornelis, Mooyaart, Antien, Nijsten, Tamar, Hollestein, Loes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431672/ https://www.ncbi.nlm.nih.gov/pubmed/34503242 http://dx.doi.org/10.3390/cancers13174431

Ejemplares similares

Limited impact of COVID‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis
por: Sangers, Tobias E., et al.
Publicado: (2022)

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse
por: Mulder, Evalyn E. A. P., et al.
Publicado: (2022)

Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data
por: Venables, Zoe Claire, et al.
Publicado: (2022)

Increasing Costs of Skin Cancer due to Increasing Incidence and Introduction of Pharmaceuticals, 2007–2017
por: NOELS, Eline, et al.
Publicado: (2020)

Genetic Concordance in Primary Cutaneous Melanoma and Matched Metastasis: A Systematic Review and Meta-Analysis
por: Kerkour, Thamila, et al.
Publicado: (2023)

Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma
por: Kamminga, Nadia C.W., et al.
Publicado: (2022)

Validation of a Market-Approved Artificial Intelligence Mobile Health App for Skin Cancer Screening: A Prospective Multicenter Diagnostic Accuracy Study
por: Sangers, Tobias, et al.
Publicado: (2022)

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model
por: Rentroia-Pacheco, Barbara, et al.
Publicado: (2023)

Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study
por: Verver, D, et al.
Publicado: (2019)

False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T‐VEC)
por: Mulder, Evalyn E. A. P., et al.
Publicado: (2021)

Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma
por: Mulder, E.E.A.P., et al.
Publicado: (2020)

Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma
por: Mulder, Evalyn E.A.P., et al.
Publicado: (2022)

An artificial intelligence based app for skin cancer detection evaluated in a population based setting
por: Smak Gregoor, Anna M., et al.
Publicado: (2023)

Outcome after treatment for sebaceous carcinoma: A multicenter study
por: In 't Veld, Eva Huis, et al.
Publicado: (2022)

Clinical findings are not helpful in detecting lentigo maligna melanoma in patients with biopsy‐proven lentigo maligna
por: Zoutendijk, J., et al.
Publicado: (2022)

Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
por: Kamminga, Nadia C. W., et al.
Publicado: (2023)

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma
por: Huis in ’t Veld, Eva A., et al.
Publicado: (2023)

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment
por: van Egmond, Sven, et al.
Publicado: (2021)

The healthy user and healthy adherer bias: a nested case-control study among statin users in the Rotterdam Study
por: Hollestein, Loes, et al.
Publicado: (2015)

Towards successful implementation of artificial intelligence in skin cancer care: a qualitative study exploring the views of dermatologists and general practitioners
por: Sangers, Tobias E., et al.
Publicado: (2022)

Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study
por: Livingstone, Elisabeth, et al.
Publicado: (2014)

Polygenic risk scores for melanoma: a stepwise process towards clinical implementation
por: Wakkee, Marlies
Publicado: (2022)

Tread carefully when considering vulvar melanoma in a child or adolescent
por: Morrel, Beth, et al.
Publicado: (2023)

Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy
por: Verver, Danielle, et al.
Publicado: (2021)

Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry
por: Jochems, Anouk, et al.
Publicado: (2019)

Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice
por: Koekelkoren, Fabiënne H.J., et al.
Publicado: (2019)

Choice of Systemic Drugs for the Management of Moderate-tosevere Psoriasis: A Cross-country Comparison Based on National Health Insurance Data
por: SBIDIAN, Emilie, et al.
Publicado: (2021)

Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy
por: Huis in ’t Veld, Eva A., et al.
Publicado: (2018)

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation
por: Mulder, E.E.A.P., et al.
Publicado: (2021)

The Association of Metastasis Pattern and Management of Metastatic Disease with Oncological Outcomes in Patients with Malignant Peripheral Nerve Sheath Tumors: A Multicenter Cohort Study
por: Acem, Ibtissam, et al.
Publicado: (2021)

Process evaluation of a multicentre randomised clinical trial of substituting surgical excisions of low-risk basal cell carcinomas from secondary to primary care
por: Noels, Eline, et al.
Publicado: (2022)

Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes
por: Verver, D., et al.
Publicado: (2018)

Oncological surgery follow-up and quality of life: meta-analysis
por: Wullaert, Lissa, et al.
Publicado: (2023)

What are the most important factors in basal cell carcinoma follow‐up care? The perspective of patients
por: van Egmond, S., et al.
Publicado: (2020)

Reporting Melanoma: A Nationwide Surveillance of State Cancer Registries
por: Raji, Kehinde O., et al.
Publicado: (2015)

Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care
por: van Egmond, Sven, et al.
Publicado: (2022)

Trichoblastic carcinosarcoma with panfollicular differentiation (panfollicular carcinosarcoma) and CTNNB1 (beta‐catenin) mutation
por: Giang, Jenny, et al.
Publicado: (2020)

Melanoma overdiagnosis: why it matters and what can be done about it
por: Bell, Katy J.L., et al.
Publicado: (2022)

Increase of sentinel lymph node melanoma staging in The Netherlands; still room and need for further improvement
por: Deckers, Eric A, et al.
Publicado: (2020)

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
por: Klaver, Yarne, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q39eqltt6pvcartdebil5u8pr9